381
« on: January 22, 2016, 05:28:24 pm »
Event 2016
Expected finalisation date, the date on which the Mediclinic Scheme has Friday, 29 January
become unconditional in all respects as required by the JSE listing rules
(the “Finalisation Date”)
Compliance certificate expected from the South African Takeover Friday, 29 January
Regulation Panel
Finalisation announcement expected to be released on SENS by Mediclinic Friday, 29 January
Finalisation announcement expected to be published in the South African Monday, 1 February
and Namibian press by Mediclinic
Application for the de-listing of Mediclinic Shares lodged with the JSE and Monday, 1 February
the NSX
Last day to trade Mediclinic Shares on the JSE and the NSX in order to Friday, 5 February
participate in the Scheme
Suspension of listing from the Main Board of the JSE and NSX of Mediclinic Monday, 8 February
Shares at commencement of trading (SA)
Listing and trading of New Al Noor Shares on the JSE (on a “when issued Monday, 8 February
basis”)
Dematerialised Scheme Participants must advise their CSDPs or brokers of Friday, 12 February
their elections in respect of the Repurchase Option and the Exchange
Option in accordance with the timeframes stipulated in the custody
agreements between each Dematerialised Scheme Participant and his
CSDP or broker as the elections close at 12h00. Certificated Scheme
Participants’ elections in respect of the Repurchase Option and the
Exchange Option to be received by the Transfer Secretaries by no later
than 12h00 on
Scheme Record Date, being the time and date on which Scheme Friday, 12 February
Participants must be recorded in the Register to participate in the Scheme
and to receive the New Al Noor Shares, 17h00 on
Mediclinic Scheme expected to become operative and Remgro Monday, 15 February
subscribes for New Al Noor Shares under the Remgro Subscription
Dematerialised Scheme Participants expected to have their accounts (held Monday, 15 February
at their CSDP or Broker) credited with the New Al Noor Shares
Admission and commencement of dealings on the London Stock Monday, 15 February
Exchange of existing Al Noor Shares and New Shares, 08h00 on
Termination of listing of Mediclinic Shares from the Main Board of the JSE Monday, 15 February
and the NSX at the commencement of trading
Certificates in respect of New Shares posted to Certificated Scheme Tuesday, 16 February
Participants who have surrendered their Documents of Title and have
elected on or prior to 12h00 on the Scheme Record Date to receive their
New Al Noor Shares in Certificated Form
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++
Jse Limited - 20160120 Mediclinic Int Ltd Merger With Al Noor Informative Notice Updated
Release Date: 20/01/2016 17:08:00 Code(s): JSER Email this JSE Sens Item to a Friend Printer Friendly Version
20160120 Mediclinic Int Ltd Merger with Al Noor Informative Notice UPDATED
Further to the FTSE/JSE notice released on 15 January 2016 in relation to the merger between
Mediclinic International (South Africa) and Al Noor Hospitals Group (UK) and following an update to the
scheme timetable, please see the new updated index treatment below:
Mediclinic International Ltd (South Africa): Merger with Al Noor
Hospitals Group (UK) - Informative Notice - Update
FTSE/JSE Africa Index Series
20 January 2016
Following shareholder approval and subject to the completion of the scheme of arrangement between
Mediclinic International Ltd (South Africa, ZAE000074142, B0PGJF0) and Al Noor Hospitals Group (UK,
GB00B8HX8Z88, B8HX8Z8), whereby Mediclinic International Ltd shareholders will receive 0.625 Al Noor
Hospitals Group shares for every Mediclinic International Ltd share held, FTSE/JSE is anticipating the
following index treatment in the FTSE/JSE Index Series:
Wednesday 03 February 2016 (after market close)
FTSE/JSE will issue a notice confirming all FTSE/JSE Index changes effective on both 08 February and 16
February.
Friday 05 February 2016
Last day of dealing in Mediclinic International Ltd shares.
Monday 08 February 2016 (from start of trading)
Mediclinic International Ltd (B0PGJF0) will be replaced by Al Noor Hospitals Group (BYYW9W4) in the
FTSE/JSE Indices. In order to avoid index tracking errors, the Al Noor Hospitals Group shares will be
added at the equivalent offer terms’ value to Mediclinic International’s last traded price.
There will be no index divisor change.
Monday 15 February 2016
Al Noor Hospitals Group will change its name to Mediclinic International plc.
Tuesday 16 February 2016 (from start of trading)
Mediclinic International plc will remain in the FTSE/JSE Indices. All index changes to bring Mediclinic’s
index shares in line with the JSE issued shares (as notified after market close on Wednesday 03 February
2016) will become effective.
Notes:
1 All dates and times may be changed by mutual agreement between Mediclinic and Al Noor and/or may be subject to the
obtaining of certain regulatory approvals. Any change to the abovementioned timetable will be published on SENS.
2 All times given are local times in South Africa.
3 Mediclinic Shares may not be dematerialised or rematerialised after Friday, 5 February 2016 (or such later date as Mediclinic
may announce if the dates and times above are changed).
4 Existing Al Noor Shares will trade on the London Stock Exchange cum Special Dividend up until and including Wednesday,
10 February 2016 and trade ex-Special Dividend from Thursday, 11 February 2016. As Mediclinic Shareholders who receive
New Al Noor Shares will not be entitled to receive the Special Dividend the New Al Noor Shares will trade ex-Special Dividend
on the JSE from Monday, 8 February 2016.
Stellenbosch
19 January 2016
+++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++++